USPTO serial 90080315
SHERPA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Nov 9, 2021
- Examiner
- EVANKO, PATRICIA MALESARDI
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with SHERPA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $548*
Plus Government fees of $650
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Laura C. Miller
Laura C. Miller KILPATRICK TOWNSEND & STOCKTON LLP1001 WEST FOURTH STREETWINSTON-SALEM, NC 27101UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Design of algorithms and models for use in scientific and medical research, all in the field of bioinformatics, genomics and gene expression research and development; platform as a service (PAAS) featuring computer software platforms for using algorithms to analyze cells, antigens, tissues, gene expressions, gene sequences, genome annotation, antigen characteristics and immunological responses, transcriptome characterization, and genome mapping for medical diagnosis and treatment; platform as a service (PAAS) featuring computer software platforms for using algorithms to predict antigen characteristics and immunological responses; providing data analysis and interpretation regarding antigen characteristics and immunological responses, and research and design relating thereto | ACTIVE | Dec 17, 2020 |
| 044 | Analysis of cells, antigens, tissues, gene expressions, gene sequences, genome annotation, transcriptome characterization, and genome mapping medical diagnosis and treatment and drug design and development; preparation of reports relating to gene expressions, gene and genome sequences, genome interaction and annotation, antigen characteristics and immunological response, transcriptome analysis and characterization, and genome mapping for medical diagnosis and treatment and drug design and development | ACTIVE | Dec 17, 2020 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Personalis, Inc.
- Other trademarks owned by Personalis, Inc.
- Other trademarks owned by Personalis, Inc.
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named SHERPA
- Prosecution event R.PR explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 9, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 5, 2021 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Oct 4, 2021 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Sep 21, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 21, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 20, 2021 | ALIE | ASSIGNED TO LIE | — |
| Sep 14, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 8, 2021 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 8, 2021 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 8, 2021 | CNRT | SU - NON-FINAL ACTION - WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 20, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 19, 2021 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Aug 19, 2021 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Aug 19, 2021 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Aug 16, 2021 | IUAF | USE AMENDMENT FILED | — |
| Aug 16, 2021 | EXT1 | SOU EXTENSION 1 FILED | — |
| Aug 16, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 16, 2021 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Feb 16, 2021 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Dec 22, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 22, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 2, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 17, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 17, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 27, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 1, 2020 | NWAP | NEW APPLICATION ENTERED | — |